doi:10.16150/j.1671-2870.2016.06.002

[1] Balderman SR, Li AJ, Hoffman CM, et al.Targeting of the bone marrow microenvironment improves outcome in a murine model of myelodysplastic syndrome[J]. Blood,2016,127(5):616-625.
[2] Greenberg PL.Synergistic Interactions of molecular and clinical advances for characterizing the myelodysplastic syndromes[J]. J Natl Compr Canc Netw,2015,13(7):829-832.
[3] Xiong H, Yang XY, Han J, et al.Cytokine expression patterns and mesenchymal stem cell karyotypes from the bone marrow microenvironment of patients with myelodysplastic syndromes[J]. Braz J Med Biol Res,2015, 48(3):207-213.
[4] Schepers K, Pietras EM, Reynaud D, et al.Myeloproli-ferative neoplasia remodels the endosteal bone marrow niche into a self-reinforcing leukemic niche[J]. Cell Stem Cell,2013,13(3):285-299.
[5] Bakker E, Qattan M, Mutti L, et al.The role of microenvironment and immunity in drug response in leukemia[J]. Biochim Biophys Acta,2016,1863(3):414-426.
[6] Hanoun M, Zhang D, Mizoguchi T, et al.Acute myelogenous leukemia-induced sympathetic neuropathy promotes malignancy in an altered hematopoietic stem cell niche[J]. Cell Stem Cell,2014,15(3):365-375.
[7] Wang L, Zhang H, Rodriguez S, et al.Notch-dependent repression of miR-155 in the bone marrow niche regulates hematopoiesis in an NF-κB-dependent manner[J]. Cell Stem Cell,2014,15(1):51-65.
[8] Zhao ZG, Xu W, Yu HP, et al.Functional characteristics of mesenchymal stem cells derived from bone marrow of patients with myelodysplastic syndromes[J]. Cancer Lett,2012,317(2):136-143.
[9] Geyh S, Oz S, Cadeddu RP, et al.Insufficient stromal support in MDS results from molecular and functional deficits of mesenchymal stromal cells[J]. Leukemia,2013, 27(9):1841-1851.
[10] Greenbaum A, Hsu YM, Day RB, et al.CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance[J]. Nature,2013,495(7440):227-230.
[11] Sochacki AL, Fischer MA, Savona MR.Therapeutic approaches in myelofibrosis and myelodysplastic/myeloproliferative overlap syndromes[J]. Onco Targets Ther,2016, 9:2273-2286.
[12] Jia P, Xu YJ, Zhang ZL, et al.Ferric ion could facilitate osteoclast differentiation and bone resorption through the production of reactive oxygen species[J]. J Orthop Res,2012,30(11):1843-1852.
[13] Raaijmakers MH, Mukherjee S, Guo S, et al.Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia[J]. Nature,2010,464(7290):852-857.
[14] Kode A, Manavalan JS, Mosialou I, et al.Leukaemogenesis induced by an activating β-catenin mutation in osteoblasts[J]. Nature,2014,506(7487):240-244.
[15] Teofili L, Martini M, Nuzzolo ER, et al.Endothelial progenitor cell dysfunction in myelodysplastic syndromes: possible contribution of a defective vascular niche to myelodysplasia[J]. Neoplasia,2015,17(5):401-409.
[16] Kim CK, Han DH, Ji YS, et al.Biomarkers of angiogenesis as prognostic factors in myelodysplastic syndrome patients treated with hypomethylating agents[J]. Leuk Res,2016,50:21-28.
[17] Ding L, Saunders TL, Enikolopov G, et al.Endothelial and perivascular cells maintain haematopoietic stem cells[J]. Nature,2012,481(7382):457-462.
[18] Ohmori S, Ohmori M, Yamagishi M, et al.MDS-macrophage derived inhibitory activity on myelopoiesis of MDS abnormal clones[J]. Br J Haematol,1993,83(3):388-391.
[19] Saito T, Usui N, Asai O, et al.Pseudo-Gaucher cell proliferation associated with myelodysplastic syndrome[J]. Int J Hematol,2007,85(4):350-353.
[20] Allampallam K, Shetty V, Mundle S, et al.Biological significance of proliferation, apoptosis, cytokines, and monocyte/macrophage cells in bone marrow biopsies of 145 patients with myelodysplastic syndrome[J]. Int J Hematol,2002,75(3):289-297.
[21] Nybakken G, Gratzinger D.Myelodysplastic syndrome macrophages have aberrant iron storage and heme oxygenase-1 expression[J]. Leuk Lymphoma,2016,57(8):1893-1902.
[22] Powers MP, Nishino H, Luo Y, et al.Polymorphisms in TGFbeta and TNFalpha are associated with the myelodysplastic syndrome phenotype[J]. Arch Pathol Lab Med,2007,131(12):1789-1793.
[23] Velegraki M, Papakonstanti E, Mavroudi I, et al.Impaired clearance of apoptotic cells leads to HMGB1 release in the bone marrow of patients with myelodysplastic syndromes and induces TLR4-mediated cytokine production[J]. Haematologica,2013,98(8):1206-1215.
[24] Cachaço AS, Carvalho T, Santos AC, et al.TNF-alpha regulates the effects of irradiation in the mouse bone marrow microenvironment[J]. PLoS One,2010,5(2):e8980.
[25] 张翼鷟, 达万明, 赵丹丹, 等. 骨髓基质细胞衍生因子1及其受体在骨髓增生异常综合征患者中的表达[J]. 中华医学杂志,2011,91(46): 3275-3277.
[26] Yang R, Pu J, Guo J, et al.The biological behavior of SDF-1/CXCR4 in patients with myelodysplastic syndrome[J]. Med Oncol,2012,29(2):1202-1208.
[27] Wang J, Xiao Z.Mesenchymal stem cells in pathogenesis of myelodysplastic syndromes[J]. Stem Cell Investig,2014, 1:16.
[28] Legros L, Slama B, Karsenti JM, et al.Treatment of myelodysplastic syndromes with excess of blasts by bevacizumab is well tolerated and is associated with a decrease of VEGF plasma level[J]. Ann Hematol,2012,91(1):39-46.
[29] Teofili L, Martini M, Nuzzolo ER, et al.Endothelial progenitor cell dysfunction in myelodysplastic syndromes: possible contribution of a defective vascular niche to myelodysplasia[J]. Neoplasia,2015,17(5):401-409.
[30] 费成明, 顾树程, 赵佑山, 等. Notch配体Delta-like-1和Jagged-1 mRNA在骨髓增生异常综合征患者骨髓间充质干细胞中表达研究[J]. 中国实验血液学杂志,2014, 22(6):1656-1660.
[31] Qi X, Chen Z, Liu D, et al.Expression of Dlk1 gene in myelodysplastic syndrome determined by microarray, and its effects on leukemia cells[J]. Int J Mol Med,2008,22(1):61-68.
[32] Xu J, Suzuki M, Niwa Y, et al.Clinical significance of nuclear non-phosphorylated beta-catenin in acute myeloid leukaemia and myelodysplastic syndrome[J]. Br J Haematol,2008,140(4):394-401.
[33] Reins J, Mossner M, Neumann M, et al.Transcriptional down-regulation of the Wnt antagonist SFRP1 in haematopoietic cells of patients with different risk types of MDS[J]. Leuk Res,2010,34(12):1610-1616.
[34] Li S, Fan R, Zhao XL, et al.CXXC4 mRNA levels are associated with clinicopathological parameters and survival of myelodysplastic syndrome patients[J]. Leuk Res,2014,38(9):1072-1078.
[35] Lin S, Li J, Zhou W, et al.BIIB021, an Hsp90 inhibitor, effectively kills a myelodysplastic syndrome cell line via the activation of caspases and inhibition of PI3K/Akt and NF-κB pathway proteins[J]. Exp Ther Med,2014,7(6):1539-1544.
[36] Falconi G, Fabiani E, Fianchi L, et al.Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes[J]. Exp Hematol,2016,44(1):75-83.
[37] Zou J, Hong Y, Tong Y, et al.Sonic hedgehog produced by bone marrow-derived mesenchymal stromal cells supports cell survival in myelodysplastic syndrome[J]. Stem Cells Int,2015,2015:957502.
[38] da Costa SV, Roela RA, Junqueira MS, et al. The role of p38 mitogen-activated protein kinase in serum-induced leukemia inhibitory factor secretion by bone marrow stromal cells from pediatric myelodysplastic syndromes[J]. Leuk Res,2010,34(4):507-512.
[39] 王静雅,秦铁军,徐泽锋,等. 环孢素联合沙利度胺治疗IPSS低危/中危-1骨髓增生异常综合征远期疗效影响因素分析[J]. 中华血液学杂志,2015,36(11):942-946.
[40] Medyouf H, Mossner M, Jann JC, et al.Myelodysplastic cells in patients reprogram mesenchymal stromal cells to establish a transplantable stem cell niche disease unit[J]. Cell Stem Cell,2014,14(6):824-837.
[41] Chen X, Eksioglu EA, Zhou J, et al.Induction of myelodysplasia by myeloid-derived suppressor cells[J]. J Clin Invest,2013,123(11):4595-4611.
[42] Ueda Y, Kondo M, Kelsoe G.Inflammation and the reciprocal production of granulocytes and lymphocytes in bone marrow[J]. J Exp Med,2005,201(11):1771-1780.
[43] Bouchliou I, Miltiades P, Nakou E, et al.Th17 and Foxp3(+) T regulatory cell dynamics and distribution in myelodysplastic syndromes[J]. Clin Immunol,2011,139(3):350-359.
[44] Mailloux AW, Epling-Burnette PK.Effector memory regulatory T-cell expansion marks a pivotal point of immune escape in myelodysplastic syndromes[J]. Oncoimmunology,2013,2(2):e22654.
[45] Zou JX, Rollison DE, Boulware D, et al.Altered naive and memory CD4+ T-cell homeostasis and immunosenescence characterize younger patients with myelodysplastic syndrome[J]. Leukemia,2009,23(7):1288-1296.
[46] Yue QF, Chen L, She XM, et al.Clinical prognostic factors in 86 Chinese patients with primary myelodysplastic syndromes and trisomy 8: A single institution experience[J]. Yonsei Med J,2016,57(2):358-364.
[47] Epling-Burnette PK, Bai F, Painter JS, et al.Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors[J]. Blood,2007,109(11):4816-4824.
[48] Olnes MJ, Sloand EM.Targeting immune dysregulation in myelodysplastic syndromes[J]. JAMA,2011,305(8):814-819.

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	. [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(04): 425-430.
[2]	. [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(04): 419-424.
[3]	HUANG Chen, JING Feng, YANG Zhitao, et al . Exploration and practice of construction of nursing management system in shelter hospital [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 286-290.
[4]	LIANG Jing, HUANG Chen, JIANG Yan, et al . Management strategy of nursing for prevention and control of COVID-19 in emergency infusion room [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 281-285.
[5]	ZHANG Hong, ZHU Mengmeng, et al . Safety nursing for eating in the elderly during the COVID-19 pandemic [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 277-280.
[6]	ZHOU Jianping, YANG Zhenhua, WANG Yichen, et al . Practice and thinking of the medical team of the elderly medical assistance center in the prevention and control of COVID-19 in Shanghai [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 265-269.
[7]	ZHA Qinghua, WANG Xiaoning, ZHANG Yin, et al . Exploration and practice of nucleic acid sampling outside hospital during the epidemic period of COVID-19 pandemic [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 229-233.
[8]	YU Ping, QIU Weiyu, WANG Xu, et al . Practice and exploration of drug security management in large shelter hospitals [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 221-224.
[9]	JIANG Yan, LIN Wei, HUANG Chen, et al . Exploration and practice of emergency supplies management mode in emergency department under COVID-19 pandemic [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 212-215.
[10]	TANG Jie, MA Longxin, CAO Qing, et al . Study on the construction of smart shelter hospital based on new generation information technology [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 196-204.
[11]	JIANG Yan, CHEN Ting, HUANG Chen, PAN Peiqian, JING Feng, et al . Construction and practice of emergency response capability training program for all staff in emergency medical ward under COVID-19：Emergency response strategy [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 189-195.
[12]	MENG Jun, JIN Peipei, CHEN Changqiang, CHEN Jiuming, FAN Zhenjia, CHEN Shikai, DAI Jing, et al . Emergency transformation experience of the laboratory department of a hospital designated for admission of patients with novel coronavirus infection in emergency conversion [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 184-188.
[13]	SHI Yingying, ZHONG Xu, LIU Jialin, HE Le, XIONG Shaoji, WENG Y, DING Chengwei, YANG Y, CHEN Weihon, QIU Liping, XIN Haiguang. Hospital infection prevention and control practices in anti-epidemic medical staff and workers during COVID-19 epidemic: investigation and countermeasures [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 178-183.
[14]	DING Ning, CHEN Shikai, MENG Jun, DAI Jing, JIN Peipei, et al . Correlation and influencing factors analysis of the cycle threshold value in detection of novel coronavirus nucleic acid(Omicron) and the negative conversion cycle in infected patients [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 169-173.
[15]	YANG Zhitao, CHEN Ying, JING Feng, XIE Zhihui, ZHANG Yibo, SHANG Hanbin, LIN Jingsheng, WU Wenjuan, GU Zhidong, BI Yufang, CHEN Erzhen. Practice and Exploration on the construction of medical affairs management system in large Fangcang hospitals [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 154-159.